Management of Gastro-Intestinal Toxicity of the Pi3 Kinase Inhibitor: Optimizing Future Dosing Strategies

SIMPLE SUMMARY: Targeted therapies are becoming more widespread in the treatment of indolent B-cell malignancies, as has been the case for chronic lymphocytic leukemias and small B-cell non-Hodgkin lymphomas. Due to the severity of these diseases, several drugs have received fast track approval sinc...

Descripción completa

Detalles Bibliográficos
Autores principales: Breal, Claire, Beuvon, Frederic, de Witasse-Thezy, Thibault, Dermine, Solene, Franchi-Rezgui, Patricia, Deau-Fisher, Benedicte, Willems, Lise, Grignano, Eric, Contejean, Adrien, Bouscary, Didier, Faillie, Jean Luc, Treluyer, Jean-Marc, Guerin, Corinne, Chouchana, Laurent, Vignon, Marguerite
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136502/
https://www.ncbi.nlm.nih.gov/pubmed/37190206
http://dx.doi.org/10.3390/cancers15082279

Ejemplares similares

Ejemplares similares